Skip to content

An exploratory clinical trial of repetitive transcranial magnetic stimulation in delaying cognitive and behavioral impairments in Chinese patients with amyotrophic lateral sclerosis

An exploratory clinical trial of repetitive transcranial magnetic stimulation in delaying cognitive and behavioral impairments in Chinese patients with amyotrophic lateral sclerosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100041756
Enrollment
Unknown
Registered
2021-01-04
Start date
2021-01-04
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis

Interventions

treatment group:TMS

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ALS patients must be over 18 years old. 2. The patients who must meet the revised El Escorial diagnostic criteria (Brooks et al., amyotrophic lateral sclerosis and other motor neuron disorders, 2000) are clinically diagnosed or suspected, that is, the patients have upper and lower motor neuron injury at more than two spinal cord segments. 3. After ECAs Chinese scale (Cognitive Scale score = 1), ALS patients have been screened with cognitive or behavioral disorders. 4. The forced vital capacity of ALS patients exceeded 75% of the predicted value. 5. Patients who have the ability to provide and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients with ALS have undergone tracheotomy. 2. Patients with cochlear implant, cardiac pacemaker, metal implant, deep brain pacemaker (DBS) and vagus nerve stimulator. 3. Patients with other nervous system diseases, including brain tumors, epilepsy, brain trauma, schizophrenia or other neurodegenerative diseases. 4. ALS patients are in pregnancy or lactation. 5. Patients who have received transcranial magnetic stimulation or other cognitive function training.

Design outcomes

Primary

MeasureTime frame
the score of ECAS;

Countries

China

Contacts

Public ContactXu Zhouwei

Shanghai Sixth People's Hospital

xzwsp@sina.com+86 15921704083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026